Full-genome sequences of the first two SARS-CoV-2 viruses from India
Background & objectives: Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has globally affected 195 countries. In India, suspected cases were screened for SARS-CoV-2 as per the advisory of the Ministry of Health and Family Welfare. The objective of this study was...
Saved in:
Published in | Indian journal of medical research (New Delhi, India : 1994) Vol. 151; no. 2; pp. 200 - 209 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
India
Wolters Kluwer India Pvt. Ltd
01.02.2020
Medknow Publications and Media Pvt. Ltd Scientific Scholar Wolters Kluwer - Medknow |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background & objectives: Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has globally affected 195 countries. In India, suspected cases were screened for SARS-CoV-2 as per the advisory of the Ministry of Health and Family Welfare. The objective of this study was to characterize SARS-CoV-2 sequences from three identified positive cases as on February 29, 2020.
Methods: Throat swab/nasal swab specimens for a total of 881 suspected cases were screened by E gene and confirmed by RdRp (1), RdRp (2) and N gene real-time reverse transcription-polymerase chain reactions and next-generation sequencing. Phylogenetic analysis, molecular characterization and prediction of B- and T-cell epitopes for Indian SARS-CoV-2 sequences were undertaken.
Results: Three cases with a travel history from Wuhan, China, were confirmed positive for SARS-CoV-2. Almost complete (29,851 nucleotides) genomes of case 1, case 3 and a fragmented genome for case 2 were obtained. The sequences of Indian SARS-CoV-2 though not identical showed high (~99.98%) identity with Wuhan seafood market pneumonia virus (accession number: NC 045512). Phylogenetic analysis showed that the Indian sequences belonged to different clusters. Predicted linear B-cell epitopes were found to be concentrated in the S1 domain of spike protein, and a conformational epitope was identified in the receptor-binding domain. The predicted T-cell epitopes showed broad human leucocyte antigen allele coverage of A and B supertypes predominant in the Indian population.
Interpretation & conclusions: The two SARS-CoV-2 sequences obtained from India represent two different introductions into the country. The genetic heterogeneity is as noted globally. The identified B- and T-cell epitopes may be considered suitable for future experiments towards the design of vaccines and diagnostics. Continuous monitoring and analysis of the sequences of new cases from India and the other affected countries would be vital to understand the genetic evolution and rates of substitution of the SARS-CoV-2. |
---|---|
AbstractList | Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has globally affected 195 countries. In India, suspected cases were screened for SARS-CoV-2 as per the advisory of the Ministry of Health and Family Welfare. The objective of this study was to characterize SARS-CoV-2 sequences from three identified positive cases as on February 29, 2020.Background & objectivesSince December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has globally affected 195 countries. In India, suspected cases were screened for SARS-CoV-2 as per the advisory of the Ministry of Health and Family Welfare. The objective of this study was to characterize SARS-CoV-2 sequences from three identified positive cases as on February 29, 2020.Throat swab/nasal swab specimens for a total of 881 suspected cases were screened by E gene and confirmed by RdRp (1), RdRp (2) and N gene real-time reverse transcription-polymerase chain reactions and next-generation sequencing. Phylogenetic analysis, molecular characterization and prediction of B- and T-cell epitopes for Indian SARS-CoV-2 sequences were undertaken.MethodsThroat swab/nasal swab specimens for a total of 881 suspected cases were screened by E gene and confirmed by RdRp (1), RdRp (2) and N gene real-time reverse transcription-polymerase chain reactions and next-generation sequencing. Phylogenetic analysis, molecular characterization and prediction of B- and T-cell epitopes for Indian SARS-CoV-2 sequences were undertaken.Three cases with a travel history from Wuhan, China, were confirmed positive for SARS-CoV-2. Almost complete (29,851 nucleotides) genomes of case 1, case 3 and a fragmented genome for case 2 were obtained. The sequences of Indian SARS-CoV-2 though not identical showed high (~99.98%) identity with Wuhan seafood market pneumonia virus (accession number: NC 045512). Phylogenetic analysis showed that the Indian sequences belonged to different clusters. Predicted linear B-cell epitopes were found to be concentrated in the S1 domain of spike protein, and a conformational epitope was identified in the receptor-binding domain. The predicted T-cell epitopes showed broad human leucocyte antigen allele coverage of A and B supertypes predominant in the Indian population.ResultsThree cases with a travel history from Wuhan, China, were confirmed positive for SARS-CoV-2. Almost complete (29,851 nucleotides) genomes of case 1, case 3 and a fragmented genome for case 2 were obtained. The sequences of Indian SARS-CoV-2 though not identical showed high (~99.98%) identity with Wuhan seafood market pneumonia virus (accession number: NC 045512). Phylogenetic analysis showed that the Indian sequences belonged to different clusters. Predicted linear B-cell epitopes were found to be concentrated in the S1 domain of spike protein, and a conformational epitope was identified in the receptor-binding domain. The predicted T-cell epitopes showed broad human leucocyte antigen allele coverage of A and B supertypes predominant in the Indian population.The two SARS-CoV-2 sequences obtained from India represent two different introductions into the country. The genetic heterogeneity is as noted globally. The identified B- and T-cell epitopes may be considered suitable for future experiments towards the design of vaccines and diagnostics. Continuous monitoring and analysis of the sequences of new cases from India and the other affected countries would be vital to understand the genetic evolution and rates of substitution of the SARS-CoV-2.Interpretation & conclusionsThe two SARS-CoV-2 sequences obtained from India represent two different introductions into the country. The genetic heterogeneity is as noted globally. The identified B- and T-cell epitopes may be considered suitable for future experiments towards the design of vaccines and diagnostics. Continuous monitoring and analysis of the sequences of new cases from India and the other affected countries would be vital to understand the genetic evolution and rates of substitution of the SARS-CoV-2. Background & objectives: Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has globally affected 195 countries. In India, suspected cases were screened for SARS-CoV-2 as per the advisory of the Ministry of Health and Family Welfare. The objective of this study was to characterize SARS-CoV-2 sequences from three identified positive cases as on February 29, 2020. Methods: Throat swab/nasal swab specimens for a total of 881 suspected cases were screened by E gene and confirmed by RdRp (1), RdRp (2) and N gene real-time reverse transcription-polymerase chain reactions and next-generation sequencing. Phylogenetic analysis, molecular characterization and prediction of B- and T-cell epitopes for Indian SARS-CoV-2 sequences were undertaken. Results: Three cases with a travel history from Wuhan, China, were confirmed positive for SARS-CoV-2. Almost complete (29,851 nucleotides) genomes of case 1, case 3 and a fragmented genome for case 2 were obtained. The sequences of Indian SARS-CoV-2 though not identical showed high (~99.98%) identity with Wuhan seafood market pneumonia virus (accession number: NC 045512). Phylogenetic analysis showed that the Indian sequences belonged to different clusters. Predicted linear B-cell epitopes were found to be concentrated in the S1 domain of spike protein, and a conformational epitope was identified in the receptor-binding domain. The predicted T-cell epitopes showed broad human leucocyte antigen allele coverage of A and B supertypes predominant in the Indian population. Interpretation & conclusions: The two SARS-CoV-2 sequences obtained from India represent two different introductions into the country. The genetic heterogeneity is as noted globally. The identified B- and T-cell epitopes may be considered suitable for future experiments towards the design of vaccines and diagnostics. Continuous monitoring and analysis of the sequences of new cases from India and the other affected countries would be vital to understand the genetic evolution and rates of substitution of the SARS-CoV-2. Background & objectives: Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has globally affected 195 countries. In India, suspected cases were screened for SARS-CoV-2 as per the advisory of the Ministry of Health and Family Welfare. The objective of this study was to characterize SARS-CoV-2 sequences from three identified positive cases as on February 29, 2020. Methods: Throat swab/nasal swab specimens for a total of 881 suspected cases were screened by E gene and confirmed by RdRp (1), RdRp (2) and N gene real-time reverse transcription-polymerase chain reactions and next-generation sequencing. Phylogenetic analysis, molecular characterization and prediction of B- and T-cell epitopes for Indian SARS-CoV-2 sequences were undertaken. Results: Three cases with a travel history from Wuhan, China, were confirmed positive for SARS-CoV-2. Almost complete (29,851 nucleotides) genomes of case 1, case 3 and a fragmented genome for case 2 were obtained. The sequences of Indian SARS-CoV-2 though not identical showed high (~99.98%) identity with Wuhan seafood market pneumonia virus (accession number: NC 045512). Phylogenetic analysis showed that the Indian sequences belonged to different clusters. Predicted linear B-cell epitopes were found to be concentrated in the S1 domain of spike protein, and a conformational epitope was identified in the receptor-binding domain. The predicted T-cell epitopes showed broad human leucocyte antigen allele coverage of A and B supertypes predominant in the Indian population. Interpretation & conclusions: The two SARS-CoV-2 sequences obtained from India represent two different introductions into the country. The genetic heterogeneity is as noted globally. The identified B- and T-cell epitopes may be considered suitable for future experiments towards the design of vaccines and diagnostics. Continuous monitoring and analysis of the sequences of new cases from India and the other affected countries would be vital to understand the genetic evolution and rates of substitution of the SARS-CoV-2. Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has globally affected 195 countries. In India, suspected cases were screened for SARS-CoV-2 as per the advisory of the Ministry of Health and Family Welfare. The objective of this study was to characterize SARS-CoV-2 sequences from three identified positive cases as on February 29, 2020. Throat swab/nasal swab specimens for a total of 881 suspected cases were screened by E gene and confirmed by RdRp (1), RdRp (2) and N gene real-time reverse transcription-polymerase chain reactions and next-generation sequencing. Phylogenetic analysis, molecular characterization and prediction of B- and T-cell epitopes for Indian SARS-CoV-2 sequences were undertaken. Three cases with a travel history from Wuhan, China, were confirmed positive for SARS-CoV-2. Almost complete (29,851 nucleotides) genomes of case 1, case 3 and a fragmented genome for case 2 were obtained. The sequences of Indian SARS-CoV-2 though not identical showed high (~99.98%) identity with Wuhan seafood market pneumonia virus (accession number: NC 045512). Phylogenetic analysis showed that the Indian sequences belonged to different clusters. Predicted linear B-cell epitopes were found to be concentrated in the S1 domain of spike protein, and a conformational epitope was identified in the receptor-binding domain. The predicted T-cell epitopes showed broad human leucocyte antigen allele coverage of A and B supertypes predominant in the Indian population. The two SARS-CoV-2 sequences obtained from India represent two different introductions into the country. The genetic heterogeneity is as noted globally. The identified B- and T-cell epitopes may be considered suitable for future experiments towards the design of vaccines and diagnostics. Continuous monitoring and analysis of the sequences of new cases from India and the other affected countries would be vital to understand the genetic evolution and rates of substitution of the SARS-CoV-2. |
Audience | Academic |
Author | Potdar, Varsha Yadav, Pragya Nyayanit, Dimpal Agrawal, Megha Choudhary, Manohar Jadhav, Santosh Basu, Atanu Shete-Aich, Anita Cherian, Sarah Abraham, Priya Majumdar, Triparna |
AuthorAffiliation | 4 Bioinformatics & Data Management Group, ICMR-National Institute of Virology, Pune, Maharashtra, India 3 Electron Microscopy, ICMR-National Institute of Virology, Pune, Maharashtra, India 1 Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune, Maharashtra, India 2 Influenza Group, ICMR-National Institute of Virology, Pune, Maharashtra, India ICMR-National Institute of Virology, Pune, Maharashtra, India |
AuthorAffiliation_xml | – name: 1 Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune, Maharashtra, India – name: 3 Electron Microscopy, ICMR-National Institute of Virology, Pune, Maharashtra, India – name: 2 Influenza Group, ICMR-National Institute of Virology, Pune, Maharashtra, India – name: ICMR-National Institute of Virology, Pune, Maharashtra, India – name: 4 Bioinformatics & Data Management Group, ICMR-National Institute of Virology, Pune, Maharashtra, India |
Author_xml | – sequence: 1 givenname: Pragya surname: Yadav fullname: Yadav, Pragya organization: Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune, Maharashtra – sequence: 2 givenname: Varsha surname: Potdar fullname: Potdar, Varsha organization: Influenza Group, ICMR-National Institute of Virology, Pune, Maharashtra – sequence: 3 givenname: Manohar surname: Choudhary fullname: Choudhary, Manohar organization: Influenza Group, ICMR-National Institute of Virology, Pune, Maharashtra – sequence: 4 givenname: Dimpal surname: Nyayanit fullname: Nyayanit, Dimpal organization: Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune, Maharashtra – sequence: 5 givenname: Megha surname: Agrawal fullname: Agrawal, Megha organization: Bioinformatics & Data Management Group, ICMR-National Institute of Virology, Pune, Maharashtra – sequence: 6 givenname: Santosh surname: Jadhav fullname: Jadhav, Santosh organization: Bioinformatics & Data Management Group, ICMR-National Institute of Virology, Pune, Maharashtra – sequence: 7 givenname: Triparna surname: Majumdar fullname: Majumdar, Triparna organization: Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune, Maharashtra – sequence: 8 givenname: Anita surname: Shete-Aich fullname: Shete-Aich, Anita organization: Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune, Maharashtra – sequence: 9 givenname: Atanu surname: Basu fullname: Basu, Atanu organization: Electron Microscopy & ICMR-National Institute of Virology, Pune, Maharashtra – sequence: 10 givenname: Priya surname: Abraham fullname: Abraham, Priya organization: ICMR-National Institute of Virology, Pune, Maharashtra – sequence: 11 givenname: Sarah surname: Cherian fullname: Cherian, Sarah organization: Bioinformatics & Data Management Group, ICMR-National Institute of Virology, Pune, Maharashtra |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32242873$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks1vFCEYxompsR9692Qm8eJlVj5mBuZislltXVM1adUrYZmXLVsGKsx00_9e1m3rtlEzZCDwe1544DlEez54QOglwZOKYPbWrvo4mX_6fCabhkmKn6AD3PK6bAmv9n6PSVm3pNlHhymtMCYt5e0ztM8orajg7AC9Px6dK5fgQw9Fgp8jeA2pCKYYLqAwNqahGNahOJ-enZez8KOkxbWNY8qMiaEv5r6z6jl6apRL8OK2P0Lfjz98m30sT7-ezGfT01LXDYVSkAo0r7ToVMVA1UoYXZMOCDOLtqaMLrQRzGCMOwON6fIZWU0IawXPE0KwI_RuW_dqXPTQafBDVE5eRdureCODsvLhircXchmuJae14HWTC7y5LRBDtpoG2dukwTnlIYxJUiYaygXjJKOvH6GrMEaf7UlaYUwFbUX7h1oqB9J6E_K-elNUTpvsqGL5l6nJX6j8ddBbnZ_U2Dz_QPBq1-i9w7t3ywDeAjqGlCKYe4RguYmG3ERD7kQjS5pHEm0HNdiwuSrr_if8shWugxsgpks3riHKfK5LH9b_1OWG5U665F262C_DQNkK |
CitedBy_id | crossref_primary_10_1007_s42398_020_00123_z crossref_primary_10_36222_ejt_1094218 crossref_primary_10_4103_ijmr_IJMR_3418_20 crossref_primary_10_1007_s11010_020_04027_8 crossref_primary_10_4103_ijmr_IJMR_2257_20 crossref_primary_10_1007_s12038_020_00046_1 crossref_primary_10_2174_2666796701999200831105801 crossref_primary_10_4103_jfmpc_jfmpc_462_20 crossref_primary_10_12688_wellcomeopenres_16768_2 crossref_primary_10_12688_wellcomeopenres_16768_1 crossref_primary_10_3389_fcimb_2020_576875 crossref_primary_10_4103_ijmr_IJMR_2251_20 crossref_primary_10_4103_ijmr_IJMR_3667_20 crossref_primary_10_22207_JPAM_14_SPL1_25 crossref_primary_10_3389_fcimb_2022_736397 crossref_primary_10_1016_j_crmicr_2021_100079 crossref_primary_10_3389_fgene_2021_630542 crossref_primary_10_4103_ijmr_IJMR_2711_20 crossref_primary_10_1080_02648725_2021_1966920 crossref_primary_10_3389_fimmu_2022_940715 crossref_primary_10_3389_fpubh_2020_00216 crossref_primary_10_51483_AFJPS_1_1_2021_16_39 crossref_primary_10_2196_20735 crossref_primary_10_1128_mSystems_00505_20 crossref_primary_10_1007_s11262_021_01826_z crossref_primary_10_3389_fgene_2021_586569 crossref_primary_10_1016_j_heliyon_2021_e06836 crossref_primary_10_3389_fcimb_2021_753249 crossref_primary_10_1007_s12088_020_00869_4 crossref_primary_10_24017_covid_15 crossref_primary_10_3389_fmed_2021_781287 crossref_primary_10_3748_wjg_v29_i14_2064 crossref_primary_10_1002_jmv_26926 crossref_primary_10_1016_j_heliyon_2022_e09910 crossref_primary_10_26508_lsa_202101213 crossref_primary_10_2174_1574887118666230413092826 crossref_primary_10_4103_ijmr_IJMR_1253_20 crossref_primary_10_2174_1389201022666210322124348 crossref_primary_10_1007_s12038_021_00145_7 crossref_primary_10_1080_07391102_2022_2038272 |
Cites_doi | 10.1002/jmv.25698 10.1073/pnas.0403492101 10.1038/s41467-019-10280-3 10.1126/science.1116480 10.4049/jimmunol.162.2.791 10.1128/MMBR.69.4.635-664.2005 10.1038/s41579-018-0118-9 10.3201/eid2405.171844 10.1002/jmv.25678 10.1002/gch2.1018 10.1093/molbev/msw054 10.1016/S0140-6736(20)30211-7 10.1056/NEJMoa2001017 10.1016/j.meegid.2020.104212 10.1016/S0140-6736(20)30251-8 10.1038/emi.2012.26 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2020 Medknow Publications and Media Pvt. Ltd. 2020. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright: © 2020 Indian Journal of Medical Research 2020 |
Copyright_xml | – notice: COPYRIGHT 2020 Medknow Publications and Media Pvt. Ltd. – notice: 2020. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright: © 2020 Indian Journal of Medical Research 2020 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 88I 8AF 8AO 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO FYUFA GHDGH GNUQQ GUQSH HCIFZ K9. M0S M1P M2O M2P MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U S0X 7X8 5PM |
DOI | 10.4103/ijmr.IJMR_663_20 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College Coronavirus Research Database ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library SciTech Premium Collection (via ProQuest) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Research Library Science Database Research Library (Corporate) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic SIRS Editorial MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 0975-9174 |
EndPage | 209 |
ExternalDocumentID | PMC7258756 A623243232 32242873 10_4103_ijmr_IJMR_663_20 10.4103/ijmr.IJMR_663_20_200_Full-genome sequence |
Genre | Journal Article |
GeographicLocations | India China United States--US Germany |
GeographicLocations_xml | – name: India – name: China – name: Germany – name: United States--US |
GroupedDBID | --- .55 29I 2WC 36B 5GY 5VS 7X7 88E 88I 8AF 8AO 8FI 8FJ 8G5 96U ABDBF ABUWG ACGFO ACGFS ACGOD ACUHS ADBBV ADJBI AEGXH AENEX AFAZI AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU DIK DWQXO E3Z EAD EAP EAS EBD EBS EJD EMB EMK EMOBN EOJEC ESX F5P FRP FYUFA GNUQQ GUQSH GX1 H13 HCIFZ HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M2O M2P M48 ML~ O5R O5S OBODZ OVD PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RMW RNS RPM S0X SV3 TEORI TR2 TUS U5U UKHRP W2D X7M XSB .GJ 53G 8R4 8R5 AAYXX ADRAZ C1A CITATION C~6 IPNFZ M2Q OVT PPXIY Q2X RIG ZXP CGR CUY CVF ECM EIF NPM PMFND 3V. 7XB 8FK COVID K9. MBDVC PJZUB PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c562e-814ec74c8da43ea5a8fc51de13fb95232bcf83f000dfe6fd24235113987dfe883 |
IEDL.DBID | M48 |
ISSN | 0971-5916 |
IngestDate | Thu Aug 21 14:09:36 EDT 2025 Fri Jul 11 11:57:29 EDT 2025 Sat Aug 23 12:37:40 EDT 2025 Tue Jun 17 21:37:07 EDT 2025 Tue Jun 10 20:47:56 EDT 2025 Thu Apr 03 07:03:36 EDT 2025 Thu Jul 10 07:27:01 EDT 2025 Thu Apr 24 23:04:14 EDT 2025 Tue Jun 17 22:50:14 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | genomes Epitope next-generation sequencing severe acute respiratory syndrome coronavirus 2 real-time reverse transcription-polymerase chain reaction phylogeny Kerala India |
Language | English |
License | http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c562e-814ec74c8da43ea5a8fc51de13fb95232bcf83f000dfe6fd24235113987dfe883 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Equal contribution |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.4103/ijmr.IJMR_663_20 |
PMID | 32242873 |
PQID | 2400282989 |
PQPubID | 4398122 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7258756 proquest_miscellaneous_2386278371 proquest_journals_2400282989 gale_infotracmisc_A623243232 gale_infotracacademiconefile_A623243232 pubmed_primary_32242873 crossref_primary_10_4103_ijmr_IJMR_663_20 crossref_citationtrail_10_4103_ijmr_IJMR_663_20 wolterskluwer_medknow_10_4103_ijmr_IJMR_663_20_200_Full-genome_sequence |
PublicationCentury | 2000 |
PublicationDate | 20200201 |
PublicationDateYYYYMMDD | 2020-02-01 |
PublicationDate_xml | – month: 2 year: 2020 text: 20200201 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | India |
PublicationPlace_xml | – name: India – name: New Delhi |
PublicationTitle | Indian journal of medical research (New Delhi, India : 1994) |
PublicationTitleAlternate | Indian J Med Res |
PublicationYear | 2020 |
Publisher | Wolters Kluwer India Pvt. Ltd Medknow Publications and Media Pvt. Ltd Scientific Scholar Wolters Kluwer - Medknow |
Publisher_xml | – name: Wolters Kluwer India Pvt. Ltd – name: Medknow Publications and Media Pvt. Ltd – name: Scientific Scholar – name: Wolters Kluwer - Medknow |
References | Baruah (R27-16-20241212) 2020; 92 Cui (R2-16-20241212) 2019; 17 Lu (R6-16-20241212) 2020; 395 Li (R10-16-20241212) 2005; 309 O'Neil (R25-16-20241212) 1999; 162 Kirchdoerfer (R23-16-20241212) 2019; 10 Weiss (R1-16-20241212) 2005; 69 Gorbalenya (R7-16-20241212) 2020; 5 Lu (R4-16-20241212) 2020; 92 Chen (R5-16-20241212) 2020; 395 Elbe (R17-16-20241212) 2017; 1 Yadav (R15-16-20241212) 2018; 24 Paraskevis (R8-16-20241212) 2020; 79 Buchholz (R24-16-20241212) 2004; 101 Janice Oh (R26-16-20241212) 2012; 1 Kumar (R18-16-20241212) 2016; 33 Zhu (R3-16-20241212) 2020; 382 |
References_xml | – volume: 92 start-page: 495 year: 2020 ident: R27-16-20241212 article-title: Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV publication-title: J Med Virol doi: 10.1002/jmv.25698 – volume: 101 start-page: 9804 year: 2004 ident: R24-16-20241212 article-title: Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0403492101 – volume: 10 start-page: 2342 year: 2019 ident: R23-16-20241212 article-title: Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors publication-title: Nat Commun doi: 10.1038/s41467-019-10280-3 – volume: 309 start-page: 1864 year: 2005 ident: R10-16-20241212 article-title: Structure of SARS coronavirus spike receptor-binding domain complexed with receptor publication-title: Science doi: 10.1126/science.1116480 – volume: 162 start-page: 791 year: 1999 ident: R25-16-20241212 article-title: IFN-γ down-regulates MHC expression and antigen processing in a human B cell line publication-title: J Immunol doi: 10.4049/jimmunol.162.2.791 – volume: 69 start-page: 635 year: 2005 ident: R1-16-20241212 article-title: Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus publication-title: Microbiol Mol Biol Rev doi: 10.1128/MMBR.69.4.635-664.2005 – volume: 17 start-page: 181 year: 2019 ident: R2-16-20241212 article-title: Origin and evolution of pathogenic coronaviruses publication-title: Nat Rev Microbiol doi: 10.1038/s41579-018-0118-9 – volume: 24 start-page: 898 year: 2018 ident: R15-16-20241212 article-title: Equine Encephalosis Virus in India, 2008 publication-title: Emerg Infect Dis doi: 10.3201/eid2405.171844 – volume: 92 start-page: 401 year: 2020 ident: R4-16-20241212 article-title: Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle publication-title: J Med Virol doi: 10.1002/jmv.25678 – volume: 5 start-page: 536 year: 2020 ident: R7-16-20241212 article-title: The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2 publication-title: Nature Microbiology Nature Publishing Group – volume: 1 start-page: 33 year: 2017 ident: R17-16-20241212 article-title: Data, disease and diplomacy: GISAID's innovative contribution to global health publication-title: Glob Chall doi: 10.1002/gch2.1018 – volume: 33 start-page: 1870 year: 2016 ident: R18-16-20241212 article-title: MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets publication-title: Mol Biol Evol doi: 10.1093/molbev/msw054 – volume: 395 start-page: 507 year: 2020 ident: R5-16-20241212 article-title: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study publication-title: Lancet doi: 10.1016/S0140-6736(20)30211-7 – volume: 382 start-page: 727 year: 2020 ident: R3-16-20241212 article-title: A novel coronavirus from patients with pneumonia in China, 2019 publication-title: New Engl J Med doi: 10.1056/NEJMoa2001017 – volume: 79 start-page: 104212 year: 2020 ident: R8-16-20241212 article-title: Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event publication-title: Infect Genet Evol doi: 10.1016/j.meegid.2020.104212 – volume: 395 start-page: 565 year: 2020 ident: R6-16-20241212 article-title: Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding publication-title: Lancet doi: 10.1016/S0140-6736(20)30251-8 – volume: 1 start-page: E23 year: 2012 ident: R26-16-20241212 article-title: Understanding the T cell immune response in SARS coronavirus infection publication-title: Emerg Microbes Infect doi: 10.1038/emi.2012.26 |
SSID | ssj0019279 ssj0000501129 |
Score | 2.5700316 |
Snippet | Background & objectives: Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has globally affected 195 countries. In India,... Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has globally affected 195 countries. In India, suspected cases were screened... |
SourceID | pubmedcentral proquest gale pubmed crossref wolterskluwer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 200 |
SubjectTerms | Betacoronavirus - genetics Coronavirus Infections Coronaviruses COVID-19 Epitopes, B-Lymphocyte - genetics Epitopes, T-Lymphocyte - genetics Genome, Viral Genomics Humans India Laboratories Middle East respiratory syndrome Models, Molecular Original Pandemics Phylogeny Pneumonia, Viral Protein Structure, Tertiary Reverse Transcriptase Polymerase Chain Reaction RNA, Viral - genetics SARS-CoV-2 Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Spike Glycoprotein, Coronavirus - genetics Viruses Whole genome sequencing |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9QwDLdgSAgJofG5wkBBQkI8hFuafqRP6LQxtknHw8bQvUVpmoqDXTvuY_v3Z7e50k5iL_fQuL3WceyfY8cG-IAmGJ1_I3hqM8XRQgmusjDnuUkSVQqXxc1MT74nR-fRyTSe-g23pU-r3OjERlEXtaU98hHlOlLUT2VfLv9y6hpF0VXfQuM-PKDSZSTV6bRzuBC8-Fp7qeAx4qA2TBmJPTma_Z4vPh-fTE41mlxN3b57Zum2cu5Zp9uZk4-va4pqL_80Se0903S4DU88pmTjVgiewj1XPYOHEx81fw4H5GdyqsY6d6zLnWZ1yRD9sXKGAJCtrmt2Nj494_v1Tx6yq9livUQaOn3CjisUohdwfvj1x_4R990TuEVM42hvz9k0sqowkXQmNqq0sSickGWeofsZ5rZUskSVWJQuKQsCVoi-ZKZSvKCUfAlbVV25HWBpYVyB0IE6FUe5NCrOpRQh_k-RGGFcAKMN87T1pcWpw8WFRheD2K2J3brH7gA-dXdctmU17qD9SPOhacXhU63xBwfw3ah2lR4nhAol_gSwO6DElWKHw5sZ1X6lLvU_uQrgfTdMd1L2WeXqNdJI9PtSdOVFAK9aAejeGhUieZ0ygHQgGh0B1e8ejlSzX00d7zSM0VtMAvg2ECI9bw9C_pch1DpU9yRHbyTn9d0f-AYehbRb0OSc78LWarF2bxFSrfJ3zbq5AfG9H_Q priority: 102 providerName: ProQuest |
Title | Full-genome sequences of the first two SARS-CoV-2 viruses from India |
URI | http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2020;volume=151;issue=2;spage=200;epage=209;aulast=Yadav;type=0 https://www.ncbi.nlm.nih.gov/pubmed/32242873 https://www.proquest.com/docview/2400282989 https://www.proquest.com/docview/2386278371 https://pubmed.ncbi.nlm.nih.gov/PMC7258756 |
Volume | 151 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwED_BJiEkhPgmMCojISEe3OE4iZ0nVMY-pU6oo6hvlpM4orAm0A8G_z13SZo100C8VGp9SaPz2ff75c53AK_QBSP5t4KrNNYcPZTgOvYTntgo0rlwcVjN9PA0OhoHJ5Nwcnk8ulHg4lpqR_2kxvPz_q8fv9_hgkf82g_EW7k7_Tqb949PhiOD7tP4SOC30S8p6mcwDC5jCrHfVN5TgoeIiuqg5bV36Dipq1v1hq-6mkd556KkGPfiW5XivuGoDu7B3QZhskFtEvfhhisewK1hE0N_CB-IdXKqzTpzrM2kZmXOEAuyfIpwkC0vSnY2GJ3xvfIz99nP6Xy1QBk6i8KOCzSpRzA-2P-0d8SbXgo8RYTj6E2fS1WQ6swG0tnQ6jwNReaEzJMYyaifpLmWOW6QWe6iPCOYhVhMxlrhD1rLx7BVlIV7Ckxl1mUIJKhvcZBIq8NESuHj_2SRFdZ5sLtWnkmbQuPU7-LcIOEgdRtSt9lQtwdv2iu-10U2_iH7mubDkEXgXVPbHCPAZ6NKVmYQEUaU-OHBTkcS103aHV7PqFmbnaGMWoot69iDl-0wXUm5aIUrVygjkQUqJPbCgye1AbRPjdsjcVDpgeqYRitA1by7I8X0S1XVW_khcsfIg8OOEZlZfSzyrwqhRqJmw3LM2nKe_bemnsNtn14jVMnoO7C1nK_cC8Ray6QHN9VE9WD7_f7pxxF-O5yIXrWs_gAWiiud |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9RADLZKkaASQrwJFBgkEOIwbJPJY3JAaNVSdttuD31pb8MkmagLbFL2wYo_xW_EzoukEr31soeMk008Htvf2GMDvEETjOBf2zyIQ8nRQtlchk7EI-37MrVN6BUzPTr0B6fu3tgbr8Gf-iwMpVXWOrFQ1Eke0x55j3IdKeonw08XPzl1jaLoat1CoxSLffN7hZBt_nG4g_P71nF2P59sD3jVVYDHaOsN7XmZOHBjmWhXGO1pmcaenRhbpFGIsMyJ4lSKFFVFkho_TcjhQK9EIDjHC1IKfO4NuImftUVgLxg3AA-dpaq2X2BzD_2uMizq2luiN_k2nX0Y7o2OFJp4Rd3FW2bwsjFoWcPLmZp3VjlF0effiyT6lincvQd3Kx-W9Uuhuw9rJnsAt0ZVlP4h7BCu5VT9dWpYk6vN8pSht8nSCTqcbLHK2XH_6Jhv52fcYb8ms-Ucaei0CxtmKLSP4PRa-PoY1rM8M0-BBYk2Cboq1BnZjYSWXiSE7eD_JL62tbGgVzNPxVUpc-qo8UMhpCF2K2K3arHbgvfNHRdlGY8raN_RfCha4fjUWFcHFfDdqFaW6vvkhQr8sWCzQ4krM-4O1zOqKs0wV__k2ILXzTDdSdlumcmXSCMQZwZSBLYFT0oBaN4aFTChXGFB0BGNhoDqhXdHssl5UTc8cDxEp74FXzpCpKblwcv_MoRalaqW5Khacp5d_YGv4PbgZHSgDoaH-89hw6GdiiLffRPWF7OleYHu3CJ6WawhBl-ve9H-BTZoXUM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Full-genome+sequences+of+the+first+two+SARS-CoV-2+viruses+from+India&rft.jtitle=Indian+journal+of+medical+research+%28New+Delhi%2C+India+%3A+1994%29&rft.au=Yadav%2C+Pragya&rft.au=Potdar%2C+Varsha&rft.au=Choudhary%2C+Manohar&rft.au=Nyayanit%2C+Dimpal&rft.date=2020-02-01&rft.pub=Medknow+Publications+and+Media+Pvt.+Ltd&rft.issn=0971-5916&rft.volume=151&rft.issue=2&rft_id=info:doi/10.4103%2Fijmr.IJMR_663_20&rft.externalDocID=A623243232 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0971-5916&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0971-5916&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0971-5916&client=summon |